AFG
CTSO icon

Atomi Financial Group’s Cytosorbents Corp CTSO Stock Holding History

Atomi Financial Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,443
Closed -$17.5K – 1236
2025
Q4 		$17.5K Hold
27,443
– – ﹤0.01% 1204
2025
Q3 		$25.6K Hold
27,443
– – ﹤0.01% 1164
2025
Q2 		$35.1K Sell
27,443
-200
-0.7% -$201 ﹤0.01% 1107
2025
Q1 		$27.6K Buy
27,643
+200
+0.7% +$211 ﹤0.01% 1035
2024
Q4 		$25K Sell
27,443
-6,849
-20% -$6.72K ﹤0.01% 965
2024
Q3 		$51.4K Buy
+34,292
New +$37.6K ﹤0.01% 906

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Atomi Financial Group's CTSO Position: Q1 2026 in Review

Atomi Financial Group sold out of Cytosorbents Corp (CTSO) in Q1 2026, closing a stake of 27,443 shares — an estimated $17.5K sold.

Atomi Financial Group first reported a position in CTSO in Q3 2024 and held it in 6 quarters. The position peaked at $51.4K in Q3 2024. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Atomi Financial Group reported no remaining Cytosorbents Corp position as of Q1 2026 after selling out during the quarter.
  • Atomi Financial Group sold 27,443 Cytosorbents Corp shares in Q1 2026, an estimated $17.5K.
  • Atomi Financial Group first reported a position in Cytosorbents Corp in Q3 2024 and held it in 6 quarters.
  • Atomi Financial Group's Cytosorbents Corp position peaked at $51.4K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.